Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Flax lignans, particularly secoisolariciresinol diglucoside (SDG), have garnered scientific interest for their potential cardiovascular benefits. Multiple clinical and preclinical studies suggest that flaxseed and its lignans may contribute to heart health by reducing risk factors associated with cardiovascular disease. Flax lignans are phytoestrogens with antioxidant properties, and they have been associated with modest reductions in blood pressure, total cholesterol, and LDL cholesterol in some randomized controlled trials. For example, a 2013 study published in "Hypertension" demonstrated that daily consumption of flaxseed for six months significantly reduced systolic and diastolic blood pressure in patients with peripheral artery disease. Meta-analyses also support mild lipid-lowering effects of flaxseed supplementation.

The mechanisms by which flax lignans may support heart function ("heart weakness" is not a standard medical term) include antioxidant activity, anti-inflammatory effects, and improvement of endothelial function. However, while the evidence is promising for general cardiovascular risk reduction, there is limited direct evidence that flax lignans are effective for treating established heart failure or significant "heart weakness." Most studies focus on prevention or risk factor modification rather than reversing existing cardiac dysfunction.

In summary, the use of flax lignans for general heart health has scientific validation, especially in terms of prevention and risk reduction, but direct evidence for treating "heart weakness" (i.e., heart failure) is currently limited.

More about Flax lignans
More about Heart (weakness)

Other ingredients used for Heart (weakness)

Other health conditions supported by Flax lignans

Products containing Flax lignans